IBDEI0QG ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11897,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11897,1,2,0)
;;=2^J1575
;;^UTILITY(U,$J,358.3,11897,1,3,0)
;;=3^IMMUNEGLOBULIN/HYALURONIDASE 100MG
;;^UTILITY(U,$J,358.3,11898,0)
;;=J1833^^48^580^60^^^^1
;;^UTILITY(U,$J,358.3,11898,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11898,1,2,0)
;;=2^J1833
;;^UTILITY(U,$J,358.3,11898,1,3,0)
;;=3^ISAVUCONAZONIUM 1MG
;;^UTILITY(U,$J,358.3,11899,0)
;;=J2407^^48^580^83^^^^1
;;^UTILITY(U,$J,358.3,11899,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11899,1,2,0)
;;=2^J2407
;;^UTILITY(U,$J,358.3,11899,1,3,0)
;;=3^ORITAVANCIN 10MG
;;^UTILITY(U,$J,358.3,11900,0)
;;=J2502^^48^580^86^^^^1
;;^UTILITY(U,$J,358.3,11900,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11900,1,2,0)
;;=2^J2502
;;^UTILITY(U,$J,358.3,11900,1,3,0)
;;=3^PASIREOTIDE LONG ACTING 1MG
;;^UTILITY(U,$J,358.3,11901,0)
;;=J2547^^48^580^91^^^^1
;;^UTILITY(U,$J,358.3,11901,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11901,1,2,0)
;;=2^J2547
;;^UTILITY(U,$J,358.3,11901,1,3,0)
;;=3^PERAMIVIR 1MG
;;^UTILITY(U,$J,358.3,11902,0)
;;=J2860^^48^580^100^^^^1
;;^UTILITY(U,$J,358.3,11902,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11902,1,2,0)
;;=2^J2860
;;^UTILITY(U,$J,358.3,11902,1,3,0)
;;=3^SILTUXIMAB 10MG
;;^UTILITY(U,$J,358.3,11903,0)
;;=J7121^^48^580^1^^^^1
;;^UTILITY(U,$J,358.3,11903,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11903,1,2,0)
;;=2^J7121
;;^UTILITY(U,$J,358.3,11903,1,3,0)
;;=3^5% DEXTROSE IN LAC RINGERS UP TO 1000CC
;;^UTILITY(U,$J,358.3,11904,0)
;;=J7188^^48^580^37^^^^1
;;^UTILITY(U,$J,358.3,11904,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11904,1,2,0)
;;=2^J7188
;;^UTILITY(U,$J,358.3,11904,1,3,0)
;;=3^FACTOR VIII PER IU
;;^UTILITY(U,$J,358.3,11905,0)
;;=J7205^^48^580^36^^^^1
;;^UTILITY(U,$J,358.3,11905,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11905,1,2,0)
;;=2^J7205
;;^UTILITY(U,$J,358.3,11905,1,3,0)
;;=3^FACTOR VIII FC FUSION PROTEIN PER IU
;;^UTILITY(U,$J,358.3,11906,0)
;;=J8655^^48^580^78^^^^1
;;^UTILITY(U,$J,358.3,11906,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11906,1,2,0)
;;=2^J8655
;;^UTILITY(U,$J,358.3,11906,1,3,0)
;;=3^NETUPITANT 300MG AND PALONOSETRON 0.5MG
;;^UTILITY(U,$J,358.3,11907,0)
;;=J9032^^48^580^19^^^^1
;;^UTILITY(U,$J,358.3,11907,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11907,1,2,0)
;;=2^J9032
;;^UTILITY(U,$J,358.3,11907,1,3,0)
;;=3^BELINOSTAT 10MG
;;^UTILITY(U,$J,358.3,11908,0)
;;=J9039^^48^580^21^^^^1
;;^UTILITY(U,$J,358.3,11908,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11908,1,2,0)
;;=2^J9039
;;^UTILITY(U,$J,358.3,11908,1,3,0)
;;=3^BLINATUMOMAB 1MCG
;;^UTILITY(U,$J,358.3,11909,0)
;;=J9299^^48^580^79^^^^1
;;^UTILITY(U,$J,358.3,11909,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11909,1,2,0)
;;=2^J9299
;;^UTILITY(U,$J,358.3,11909,1,3,0)
;;=3^NIVOLUMAB 1MG
;;^UTILITY(U,$J,358.3,11910,0)
;;=J9308^^48^580^93^^^^1
;;^UTILITY(U,$J,358.3,11910,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11910,1,2,0)
;;=2^J9308
;;^UTILITY(U,$J,358.3,11910,1,3,0)
;;=3^RAMUCIRUMAB 5MG
;;^UTILITY(U,$J,358.3,11911,0)
;;=J3301^^48^580^61^^^^1
;;^UTILITY(U,$J,358.3,11911,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11911,1,2,0)
;;=2^J3301
;;^UTILITY(U,$J,358.3,11911,1,3,0)
;;=3^KENALOG 10MG
;;^UTILITY(U,$J,358.3,11912,0)
;;=J3380^^48^580^109^^^^1
;;^UTILITY(U,$J,358.3,11912,1,0)
;;=^358.31IA^3^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0QG 3774 printed Dec 13, 2024@01:53:46 Page 2
IBDEI0QG ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11897,1,0)
+2 ;;=^358.31IA^3^2
+3 ;;^UTILITY(U,$J,358.3,11897,1,2,0)
+4 ;;=2^J1575
+5 ;;^UTILITY(U,$J,358.3,11897,1,3,0)
+6 ;;=3^IMMUNEGLOBULIN/HYALURONIDASE 100MG
+7 ;;^UTILITY(U,$J,358.3,11898,0)
+8 ;;=J1833^^48^580^60^^^^1
+9 ;;^UTILITY(U,$J,358.3,11898,1,0)
+10 ;;=^358.31IA^3^2
+11 ;;^UTILITY(U,$J,358.3,11898,1,2,0)
+12 ;;=2^J1833
+13 ;;^UTILITY(U,$J,358.3,11898,1,3,0)
+14 ;;=3^ISAVUCONAZONIUM 1MG
+15 ;;^UTILITY(U,$J,358.3,11899,0)
+16 ;;=J2407^^48^580^83^^^^1
+17 ;;^UTILITY(U,$J,358.3,11899,1,0)
+18 ;;=^358.31IA^3^2
+19 ;;^UTILITY(U,$J,358.3,11899,1,2,0)
+20 ;;=2^J2407
+21 ;;^UTILITY(U,$J,358.3,11899,1,3,0)
+22 ;;=3^ORITAVANCIN 10MG
+23 ;;^UTILITY(U,$J,358.3,11900,0)
+24 ;;=J2502^^48^580^86^^^^1
+25 ;;^UTILITY(U,$J,358.3,11900,1,0)
+26 ;;=^358.31IA^3^2
+27 ;;^UTILITY(U,$J,358.3,11900,1,2,0)
+28 ;;=2^J2502
+29 ;;^UTILITY(U,$J,358.3,11900,1,3,0)
+30 ;;=3^PASIREOTIDE LONG ACTING 1MG
+31 ;;^UTILITY(U,$J,358.3,11901,0)
+32 ;;=J2547^^48^580^91^^^^1
+33 ;;^UTILITY(U,$J,358.3,11901,1,0)
+34 ;;=^358.31IA^3^2
+35 ;;^UTILITY(U,$J,358.3,11901,1,2,0)
+36 ;;=2^J2547
+37 ;;^UTILITY(U,$J,358.3,11901,1,3,0)
+38 ;;=3^PERAMIVIR 1MG
+39 ;;^UTILITY(U,$J,358.3,11902,0)
+40 ;;=J2860^^48^580^100^^^^1
+41 ;;^UTILITY(U,$J,358.3,11902,1,0)
+42 ;;=^358.31IA^3^2
+43 ;;^UTILITY(U,$J,358.3,11902,1,2,0)
+44 ;;=2^J2860
+45 ;;^UTILITY(U,$J,358.3,11902,1,3,0)
+46 ;;=3^SILTUXIMAB 10MG
+47 ;;^UTILITY(U,$J,358.3,11903,0)
+48 ;;=J7121^^48^580^1^^^^1
+49 ;;^UTILITY(U,$J,358.3,11903,1,0)
+50 ;;=^358.31IA^3^2
+51 ;;^UTILITY(U,$J,358.3,11903,1,2,0)
+52 ;;=2^J7121
+53 ;;^UTILITY(U,$J,358.3,11903,1,3,0)
+54 ;;=3^5% DEXTROSE IN LAC RINGERS UP TO 1000CC
+55 ;;^UTILITY(U,$J,358.3,11904,0)
+56 ;;=J7188^^48^580^37^^^^1
+57 ;;^UTILITY(U,$J,358.3,11904,1,0)
+58 ;;=^358.31IA^3^2
+59 ;;^UTILITY(U,$J,358.3,11904,1,2,0)
+60 ;;=2^J7188
+61 ;;^UTILITY(U,$J,358.3,11904,1,3,0)
+62 ;;=3^FACTOR VIII PER IU
+63 ;;^UTILITY(U,$J,358.3,11905,0)
+64 ;;=J7205^^48^580^36^^^^1
+65 ;;^UTILITY(U,$J,358.3,11905,1,0)
+66 ;;=^358.31IA^3^2
+67 ;;^UTILITY(U,$J,358.3,11905,1,2,0)
+68 ;;=2^J7205
+69 ;;^UTILITY(U,$J,358.3,11905,1,3,0)
+70 ;;=3^FACTOR VIII FC FUSION PROTEIN PER IU
+71 ;;^UTILITY(U,$J,358.3,11906,0)
+72 ;;=J8655^^48^580^78^^^^1
+73 ;;^UTILITY(U,$J,358.3,11906,1,0)
+74 ;;=^358.31IA^3^2
+75 ;;^UTILITY(U,$J,358.3,11906,1,2,0)
+76 ;;=2^J8655
+77 ;;^UTILITY(U,$J,358.3,11906,1,3,0)
+78 ;;=3^NETUPITANT 300MG AND PALONOSETRON 0.5MG
+79 ;;^UTILITY(U,$J,358.3,11907,0)
+80 ;;=J9032^^48^580^19^^^^1
+81 ;;^UTILITY(U,$J,358.3,11907,1,0)
+82 ;;=^358.31IA^3^2
+83 ;;^UTILITY(U,$J,358.3,11907,1,2,0)
+84 ;;=2^J9032
+85 ;;^UTILITY(U,$J,358.3,11907,1,3,0)
+86 ;;=3^BELINOSTAT 10MG
+87 ;;^UTILITY(U,$J,358.3,11908,0)
+88 ;;=J9039^^48^580^21^^^^1
+89 ;;^UTILITY(U,$J,358.3,11908,1,0)
+90 ;;=^358.31IA^3^2
+91 ;;^UTILITY(U,$J,358.3,11908,1,2,0)
+92 ;;=2^J9039
+93 ;;^UTILITY(U,$J,358.3,11908,1,3,0)
+94 ;;=3^BLINATUMOMAB 1MCG
+95 ;;^UTILITY(U,$J,358.3,11909,0)
+96 ;;=J9299^^48^580^79^^^^1
+97 ;;^UTILITY(U,$J,358.3,11909,1,0)
+98 ;;=^358.31IA^3^2
+99 ;;^UTILITY(U,$J,358.3,11909,1,2,0)
+100 ;;=2^J9299
+101 ;;^UTILITY(U,$J,358.3,11909,1,3,0)
+102 ;;=3^NIVOLUMAB 1MG
+103 ;;^UTILITY(U,$J,358.3,11910,0)
+104 ;;=J9308^^48^580^93^^^^1
+105 ;;^UTILITY(U,$J,358.3,11910,1,0)
+106 ;;=^358.31IA^3^2
+107 ;;^UTILITY(U,$J,358.3,11910,1,2,0)
+108 ;;=2^J9308
+109 ;;^UTILITY(U,$J,358.3,11910,1,3,0)
+110 ;;=3^RAMUCIRUMAB 5MG
+111 ;;^UTILITY(U,$J,358.3,11911,0)
+112 ;;=J3301^^48^580^61^^^^1
+113 ;;^UTILITY(U,$J,358.3,11911,1,0)
+114 ;;=^358.31IA^3^2
+115 ;;^UTILITY(U,$J,358.3,11911,1,2,0)
+116 ;;=2^J3301
+117 ;;^UTILITY(U,$J,358.3,11911,1,3,0)
+118 ;;=3^KENALOG 10MG
+119 ;;^UTILITY(U,$J,358.3,11912,0)
+120 ;;=J3380^^48^580^109^^^^1
+121 ;;^UTILITY(U,$J,358.3,11912,1,0)
+122 ;;=^358.31IA^3^2
